Approximately 20% of breast cancers overexpress the membrane tyrosine kinase, human epidermal growth factor receptor 2 (HER2), leading to uncontrolled cell proliferation and survival through increased receptor dimerization. Here, ERBB2 is linked to breast carcinoma.